Down 14%, Time CrowdStrike: Is It Worth Buying Now?
CrowdStrike has become a pillar in AI-era cybersecurity, but a 14% decline raises the question: is it a buy? This gui...
What To Consider Before Getting A No Fee Card
Before applying for a no fee card, consider key factors that affect your financial health. Equip yourself with knowledge for better decisions.
20,624 articles
First U.S. Marijuana Stock Hits NYSE: What It Means
A landmark listed on the NYSE signals bigger access to capital and greater scrutiny for cannabis companies. Learn how...
Thursday Reads for Investors: 10 Must-See Thursday Reads
Turn Thursdays into your smartest investing ritual. This guide curates 10 essential thursday reads and translates the...
Super Micro Computer Stock Surges Today: Key Drivers
Investors are buzzing as super micro computer stock jumps on a wave of bullish momentum. This piece breaks down the c...
Bitcoin Plummets Lower Strategy's STRC: Market Shake
Bitcoin slid toward the $58,000 level as Strategy's STRC dropped to fresh lows and MSTR followed lower. This article ...
Buying Penguin Solutions Today to 10X Your Net Worth
Investing in niche AI infrastructure can offer outsized upside, but only with a plan. This article shows how buying P...
Is Viking Therapeutics Stock Going to $50? Bulls and Bears
A wide-open weight-loss drug market has investors buzzing about Viking Therapeutics. This article breaks down the bul...
Prediction: Tesla Stock Will Reach a Price in July
A controversial July forecast has investors buzzing: prediction: tesla stock will swing sharply. This article breaks ...
Prediction: Today's Inflation Report Delivers Hope, Risk
As the prediction: today's inflation report lands, investors weigh relief from cooling price pressures against stubbo...
Vanguard ETFs Using Momentum to Outpace the S&P 500
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...
Should Shares CRISPR Therapeutics Be a February Pick?
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
Former Chief Officer Sells: Read Insider Moves in Investing
When a former chief officer sells stock, investors should look beyond the headline. This guide explains why insider m...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status